baber/WOPTO huggingface dataset:
Patent DE-03773374-T1 (DE)
Inventor: JIN XIN
IPC: H04J13/00
Filed: 2003-11-04
Abstract: A method and apparatus for regulating Tx power in a multi-rate mobile device transmitter containing signal dependent gain stages. A data rate and signal format indicator signal corresponding to the transmitted signal, and a desired reference power signal are fed to a mapper that outputs a calibration value based on the desired reference power level at the antenna. The calibration value controls the power amplifier gain characteristics in real time.
Patent DE-10196091-T1 (DE)
Inventor: GILSON PAUL
IPC: A61M25/00
Filed: 2001-04-20
Abstract: An embolic protection system 1 comprises a guidewire 99 for advancing through a vasculature, the guidewire 99 having a distal end and a proximal end; an embolic protection filter 1 having a filter body 41 with a distal end and a proximal end, the filter body 41 providing for a collapsed configuration and an expanded deployed configuration. The embolic protection filter body 41 has a guidewire path for slidably receiving the guidewire 99 to permit movement of the filter 1 relative to the guidewire 99 when the filter 1 is in the collapsed configuration and the expanded deployed configuration. A delivery catheter 2 is advanceable over the guidewire 99 for delivery of the embolic protection filter 1; the delivery catheter 2 having a a proximal end and a distal end. The filter 1 is deployed from the distal end of the delivery catheter 2 into the expanded deployed configuration. A retrieval catheter 3 is also advancable over the guidewire 99 for retrieval of the filter 1, the retrieval catheter 3 having a distal end and a proximal end; and engagement elements for engaging the embolic protection filter 1 with the guidewire 99 for retrieval of the filter 1 into the retrieval catheter 3 in the collapsed configuration.
Patent DE-14425109-T1 (DE)
Title: Explosionssicheres, kugelsicheres Fenster und zugehörige Vorrichtung
Inventor: BERTOLINI ALBERTO
IPC: F41H5/26
Filed: 2014-08-20
Abstract: Druckwellenbeständiges, durchschusshemmendes Fenster (1), insbesondere zur Verwendung in einem Kraftfahrzeug, mit einem ballistischen Block (11), der einen umfangseitigen Rand (11.1) und eine Vielzahl von Scheiben aus Glas (4, 6, 8), Keramik oder Kunststoffmaterial (10, 15), die miteinander über ihre Oberflächen in einem geschichteten Verbund verbunden sind, und dazwischen angeordnete Verbundzwischenschichten (5, 7, 9, 14) aus Kunststoffmaterial oder Klebstoff hat, gekennzeichnet durch mindestens eine Randvertiefung (12) oder mehrere Randvertiefungen mit insbesondere einem rechteckigen Querschnitt, die an mindestens einem Teil oder entlang mindestens eines Teils des umfangseitigen Randes (11.1) vorgesehen ist oder sind, und durch eine Randaussparung (13), die an einer Innenfläche (11.2) des ballistischen Blocks (11) oder Fensters (1) an mindestens einem Teil oder entlang mindestens eines Teils des umfangseitigen Randes (11.1) des Fensters (1) vorgesehen ist.
Patent DE-227494-T1 (DE)
IPC: A61K31/715
Filed: 1986-10-02
Abstract: The present invention relates to a pharmaceutical composition intended for contacting with a physiological liquid characterized in that said composition is intended to be administered as a non-gelled liquid form and is intended to gel in situ, this composition containing at least one polysaccharide in aqueous solution, of the type which undergoes liquid-gel phase transition gelling in situ under the effect of an increase in the ionic strength of said physiological liquid.
Patent DE-247916-T1 (DE)
IPC: G10K11/00
Filed: 1987-04-29
Abstract: The invention relates to a device for positioning an exploratory probe in space, for example an ultrasonic probe. This device comprises an essentially rigid arm (20) whose first end (21) is articulated relative to a support holder (10) by two perpendicular articulation spindles (24, 26) and the exploratory probe (2) is mounted on a support element (30) connected to the second end (22) of the arm by at least two articulation spindles (32, 34). The support element (30) of the exploratory probe is connected to the second end (22) of the arm by means of a set of four articulation spindles (32, 34, 36, 38) which are successively disposed perpendicular to each other and in space in such a manner as to occupy a limited volume in the immediate vicinity of the exploratory probe. This device thus offers an ability for unlimited positioning in space of the exploratory probe within a space or volume which is limited or confined, which constitutes an essential technical advantage for locating targets such as concretions, renal or biliary calculi with a view to their destruction. <IMAGE>
Patent DE-451065-T1 (DE)
IPC: H02K15/00
Filed: 1991-03-29
Abstract: According to the invention, an electric motor stator is placed on a stator-support cradle (36), resting against anterior stops (38). A mandrel (14) is slipped into the central bore of the stator by actuation of a jack (55) until an expandable mandrel part (15) is brought into the region of the winding head to be formed. Through actuation of a mandrel rod (54), the expandable part (15) is caused to expand and the inner diameter of the winding head is caused to increase. The lateral jaws (21) press the periphery of the winding head around the mandrel (14). After the winding head is formed, an insulating cap is force-fitted axially by means of an insulating-cap movable support (44). The invention makes it possible to automate the placement of the insulating cap on an electrical winding head. <IMAGE>
Patent DE-794927-T1 (DE)
Inventor: TOPOL JAN DIPL ING
IPC: C02F3/00
Filed: 1995-12-04
Abstract: PCT No. PCT/CZ95/00027 Sec. 371 Date May 27, 1997 Sec. 102(e) Date May 27, 1997 PCT Filed Dec. 4, 1995 PCT Pub. No. WO96/16908 PCT Pub. Date Jun. 6, 1996Method for sewage water treatment using suspended activated sludge where sewage water is supplied to the equalizing tank being then re-pumped to the activation tank from which is supplied to the post-sedimentation tank after the clearing process and from here, after the remaining sludge sedimentation, to the drainage. The activation process is automatically interrupted after a drop of the sewage water level in the equalizing tank below the minimum level setting and the excessive sludge is then pumped off from the activation tank. The sludge re-pumping is interrupted and the activation process restored owing to the subsequent raising of the sewage water level in excess of the operation level setting.
Patent ES-2304907-T1 (ES)
Inventor: HERBERTSSON RONNY
IPC: F16B5/10
Filed: 2003-06-04
Abstract: In a system for screening off an area, a partition element substantially covers the space between two upstanding carrier elements. The partition element is catchable in the carrier elements in a temporary, unstable preparatory position. The partition element lacks the capability of remaining in the preparatory position by its own force. The partition element is further movable from the preparatory position to a fixedly locked position in the carrier elements. In a method of mounting and dismounting of a partition element on two upstanding carrier elements, the partition element is hooked in the carrier elements in the preparatory position. Thereafter, the partition element is moved to a fixedly locked position in the carrier elements.
Patent ES-2246191-T1 (ES)
Title: Metodo para predecir la respuesta a la terapia dirigida a her2.
Inventor: BACUS SARAH S
IPC: G01N33/574
Filed: 2003-12-11
Abstract: Método para identificar un tumor de mamífero que responde a una terapia dirigida a HER2, en el que el tumor de mamífero sobreexpresa HER2, comprendiendo el método la etapa de analizar una muestra obtenida a partir del tumor de mamífero para detectar un patrón de expresión, fosforilación, o expresión y fosforilación, de uno o una pluralidad de polipéptidos que consisten en: (a) polipéptido de IGFR; (b) polipéptido de EGFR; (c) polipéptido de NDF; (d) polipéptido ribosómico S6 fosforilado; (e) polipéptido de AKT fosforilado; y (f) polipéptido de ERK fosforilado; en el que el patrón detectado de expresión, fosforilación, o expresión y fosforilación, identifica tumores de mamífero.
Patent CY-1105133-T1 (CY)
Title: Εγκατασταση αιολικης ενεργειας
Inventor: WOBBEN ALOYS
IPC: F24F5/00
Filed: 2006-08-09
Abstract: Η παρούσα εφεύρεση αναφέρεται σε μία εγκατάσταση αιολικής ενέργειας, κυρίως σε μία εγκατάσταση αιολικής ενέργειας με μία διάταξη για την αφύγρανση ενός μέσου μορφής αερίου, σε έναν βασικά κλειστό χώρο μέσα στην εγκατάσταση αιολικής ενέργειας. Για να διατηρούνται χαμηλά τα έξοδα προσωπικού και τα έξοδα μεταφοράς και εφοδιασμού κατά τη διατήρηση της ικανότητας της λειτουργίας της εγκατάστασης, για την κατασκευαστική απλοποίηση και την ευρύτερη λειτουργία χωρίς συντήρηση, περιλαμβάνει η εγκατάσταση ένα πρώτο επίπεδο στοιχείο (10) και μία διάταξη ψύξης (12) για την ψύξη του πρώτου στοιχείου, σε μία θερμοκρασία κατώτερη από εκείνη του περιβάλλοντος.
Patent CY-1106901-T1 (CY)
Inventor: ELOKDAH HASSAN MAHMOUD
IPC: A61K31/404
Filed: 2007-10-02
Abstract: This invention provides compounds of the formula: wherein: X is a chemical bond, -CH<SUB>2</SUB>- or -C(O)-; R<SUB>1 </SUB>is alkyl, cycloalkyl, -CH<SUB>2</SUB>- cycloalkyl, pyridinyl, -CH<SUB>2</SUB>-pyridinyl, phenyl or benzyl; R<SUB>2 </SUB>is H, alkyl, cycloalkyl, -CH<SUB>2</SUB>-cycloalkyl, or perfluoroalkyl; R<SUB>3 </SUB>is H, halo, alkyl, perfluoroalkyl, alkoxy, cycloalkyl, -CH<SUB>2</SUB>-cycloalkyl, -NH<SUB>2</SUB>, or -NO<SUB>2</SUB>; R<SUB>4 </SUB>is optionally substituted phenyl, benzyl, benzyloxy, pyridinyl, or -CH<SUB>2</SUB>-pyridinyl, or the salt or ester forms thereof, as well as methods for using the compounds as inhibitors of plasminogen activator inhibitor-1 (PAI-1) and as therapeutic compositions for treating conditions resulting from fibrinolytic disorders such as deep vein thrombosis and coronary heart disease, and pulmonary fibrosis.
Patent CY-1109905-T1 (CY)
Inventor: NATIV DUDAI
IPC: A61Q19/08
Filed: 2010-04-06
Abstract: The present invention concerns a food supplement comprising Salvia sclarea seeds, or flour, oil or pulp or extracts obtained from the seeds as well as finished food products comprising the food supplement. The present invention further concerns a nutraceutical or cosmetic preparation comprising as an active ingredient Salvia sclarea seeds, or flour, oil or pulp or extracts obtained from the seeds.
Patent CY-1110881-T1 (CY)
Inventor: FRANKLIN RICHARD
IPC: A61P9/10
Filed: 2010-11-09
Abstract: In accordance with the present invention there is provided a method for the treatment of peripheral arterial diseases in a host comprising administering a therapeutically effective amount of compounds having the formulas (I) through (III) or analogues thereof.
Patent CY-1112282-T1 (CY)
Title: Χρηση του 4-κυκλοπροπυλομεθοξυ-ν-(3,5-διχλωρο-1-οξυδο-4-πυριδιν-4-υλο)-5-(μεθοξυ)πυριδινο-2-καρβοξαμιδιου για τη θεραπευτικη αντιμετωπιση των τραυματισμων του κρανιου
Inventor: DELAY-GOYET PHILIPPE
IPC: A61P25/00
Filed: 2012-01-26
Abstract: Η εφεύρεση αφορά στη χρήση του 4-κυκλο- προπυλομεθοξυ-Ν-(3,5-διχλωρο-1 -οξυδο-πυριδιν-4-υλο)-5-(μεθοξυ)πυριδινο-2-καρβοξαμιδίου, για την παρασκευή ενός φαρμάκου το οποίο προορίζεται για τη θεραπευτική αντιμετώπιση των εγκεφαλικών τραυματισμών.
Patent CY-1116300-T1 (CY)
Title: Παραταση της επιβιωσης ενος αλλομοσχευματος μεσω αναστολης της δραστικοτητας του συμπληρωματος
Inventor: ROTHER RUSSELL P
IPC: A61K31/16
Filed: 2015-03-02
Abstract: Παρουσιάζονται μέθοδοι παράτασης της επιβίωσης των αλλομεταμοσχευμένων κυττάρων, ιστών ή οργάνων. Αυτές οι μέθοδοι προσανατολίζονται στην χορήγηση προς τον αποδέκτη αλλομοσχεύματος ενός αναστολέα της δραστικότητας του συμπληρώματος από κοινού με ένα ή περισσότερα ανοσοκατασταλτικά και/ή ανοσοκατασταλτικές μεθόδους. Ο αναστολέας της δραστικότητας του συμπληρώματος χορηγείται χρονίως. Αυτές οι μέθοδοι έχουν καθοριστεί ούτως ώστε να βοηθούν στην πρόληψη της χρόνιας απόρριψης των αλλομοσχευμάτων. Αυτές οι μέθοδοι μπορούν, επιπροσθέτως, να χρησιμοποιηθούν σε περιπτώσεις, κατά τις οποίες ο αποδέκτης έχει προ-ευαισθητοποιηθεί στο αλλομόσχευμα ή στις οποίες υπάρχει μία αναντιστοιχία ΑΒΟ μεταξύ του αλλομοσχεύματος και του αποδέκτη.
Patent CY-1116573-T1 (CY)
Title: Συστημα τουβλων, με οριζοντιες και καθετες συνδετικες υποδοχες - οδηγους, για ολοκληρωμενες οικοδομικες εργασιες και διακοσμηση
Inventor: PAPACHATZIS DIMITRIOS
IPC: E04B2/06
Filed: 2015-08-05
Abstract: Το σύστημα τούβλων με οριζόντιες και κάθετες συνδετικές υποδοχές-οδηγούς για ολοκληρωμένη κατασκευή και διακόσμηση οικοδομών αποτελείται από παραλληλεπίπεδα, γωνιακά, σχήματος ταφ ή σταυρού τούβλα, καμπυλόγραμμα και μορφοποιημένα, τα οποία μέσω οριζόντιων και καθέτων θηλυκών εσοχών και αρσενικών προεξοχών και με τη βοήθεια των ραγών-οδηγών στη βάση τους ή προαιρετικά πάνω στις πλευρές και πάνω στην οροφή της οικοδομής, συνδέονται άρρηκτα μεταξύ τους για τη δημιουργία μίας αντισεισμικής κατασκευής τοιχοποιίας και για τη στήριξη των ορόφων και της οροφής του οικοδομής. Τα πλεονεκτήματα αυτής της εφεύρεσης είναι πολλά σε σχέση με τα ήδη υπάρχοντα οικοδομικά συστήματα, διότι: Προσφέρει νέες δυνατότητες οικοδόμησης, για εύκολη και γρήγορη κατασκευή. Προσφέρει μία ομοιόμορφη και απόλυτη συνοχή κατασκευής, η οποία καθιστά την οικοδομή αντισεισμική. Λόγω της τέλειας ένωσης των τούβλων με συνδετικά υλικά, ο εργολάβος γλιτώνει από το σοβά καθώς αυτός αντικαθίσταται από στόκο. Η εργασία κατασκευής είναι καθαρή. Ο χρόνος που απαιτείται για την ολοκλήρωση της εργασίας είναι πολύ μικρός. Συνεισφέρει στην εξοικονόμηση εργασίας και υλικών και ως αποτέλεσμα το ολικό κόστος της κατασκευής είναι πολύ μικρότερο.
Patent CY-1118925-T1 (CY)
Title: Θεραπεια ασθενειας με αναστολεις πρωτεασωματος
Inventor: DE COSTER ROLAND
IPC: A61P35/00
Filed: 2017-06-01
Abstract: Παρέχεται μέθοδος για τη θεραπεία καρκίνου σε έναν ασθενή περιλαμβάνουσα χορήγηση στον εν λόγω ασθενή ενός αναστολέα πρωτεασώματος τουλάχιστον τρεις ημέρες την εβδομάδα.
Patent CY-1119061-T1 (CY)
Title: Θεραπεια οφθαλμικων διαταραχων που χαρακτηριζονται απο αυξημενη ενδο-οφθαλμικη πιεση me sirnas
Inventor: JIMENEZ ANA I
IPC: C12N15/113
Filed: 2017-07-05
Abstract: Αποκαλύπτονται αλληλουχίες και πρωτόκολλα για θεραπεία οφθαλμικών καταστάσεων με χρήση RNA παρεμβολής. Γονίδια-στόχοι επιλέγονται από αυτά που είναι υπεύθυνα για υδατική ροή ή υδατική εκροή, ενώ ιδιαιτέρως προτιμώμενες καταστάσεις προς θεραπεία περιλαμβάνουν γλαύκωμα και ραγοειδίτιδα.
Patent CY-1119740-T1 (CY)
Title: Σταθεροποιημενα φαρμακευτικα υπομικρομετρικα εναιωρηματα και μεθοδοι σχηματισμου τους
Inventor: CASTILLO ERNESTO J
IPC: A61K47/38
Filed: 2018-01-05
Abstract: Η παρούσα εφεύρεση προσανατολίζεται σε ένα φαρμακευτικό υπομικρομετρικό εναιώρημα και σε μία μέθοδο σχηματισμού του υπομικρομετρικού εναιωρήματος. Το υπιμικρομετρικό εναιώρημα είναι χρήσιμο για τη χορήγηση μίας σχετικά υδρόφοβης και/ή μικρής διαλυτότητας θεραπευτικής ουσίας. Το υπομικρομετρικό εναιώρημα και η μέθοδος σχηματισμού του υπομικρομετρικού εναιωρήματος συνήθως χρησιμοποιούν ένα πολυμερές υλικό το οποίο συμβάλει στην αποτροπή συσσωμάτωσης του θεραπευτικού παράγοντα.
Patent GR-890300045-T1 (GR)
Title: Process for the preparation of 2,5-diamino-nitro-6-pyridine derivatives, their use in hair dyeing agents and these 2,5-diamino-6-nitro-pyridine derivatives
Inventor: CLAUSEN THOMAS
IPC: C09B51/00
Filed: 1989-05-25
Abstract: Process for the preparation of 2,5-diamino-6-nitropyridine derivatives of the general formula (1) <IMAGE> in which R<1> to R<4> denote hydrogen or the radicals alkyl, hydroxyalkyl, dihydroxyalkyl, alkoxyalkyl, alkoxycarbonyl, hydroxyl- or chlorine-substituted alkoxycarbonyl, aminoalkyl and aminoalkyl which is substituted by alkyl or hydroxyl groups, the alkyl groups having in each case 1 to 4 carbon atoms, or R<1> and R<2>, or R<3> and R<4>, form an oxazolidinone ring. The invention also relates to novel 2,5-diamino-6-nitropyridine derivatives.
Patent HR-P20120382-T1 (HR)
Inventor: H JAMES BRENTZEL JR
IPC: A61K9/00
Filed: 2012-05-08
Abstract: Uporaba kombinacije Kladribina i IFN-beta za proizvodnju lijeka za liječenje pacijenata koji imaju multiplu sklerozu i koji su otporni na barem jedan uobičajen način liječenja multiple skleroze, naznačena time da se Kladribin daje oralno u skladu sa niže navedenim uzastopnim koracima: (i)	period indukcije pri čemu se primjenjuje Kladribin i pri čemu ukupna doza Kladribina dosegnuta na završetku perioda indukcije je od oko 1.7 mg/kg do oko 3.5 mg/kg; (ii)	period bez Klardibina pri čemu se ne primjenjuje Kladribin; (iii)	period održavanja pri čemu da se primjenjuje Kladribin i pri čemu ukupna doza Kladribina koja se daje tijekom perioda održavanja je niža od ili jednaka ukupnoj dozi Kladribina dosegnutoj na završetku perioda indukcije (i); period bez Klardibina pri čemu se ne primjenjuje Kladribin. Patent sadrži još 25 patentnih zahtjeva.
Patent HR-P20120476-T1 (HR)
Inventor: MUNETO MOGI
IPC: A61P3/06
Filed: 2012-06-05
Abstract: Spoj, naznačen time, da ima formulu (I): gdje, R1 je (C1-C7)alkil-O-C(O)-, ili 5- ili 6-člani heteroaril koji ima 1, 2 ili 3 heteroatoma odabranih od N, O ili S, pri čemu je spomenuti heteroaril opcijski supstituiran s jednim do tri supstituenta odabranih od halogena, di(C1-C4)
Patent HR-P20130331-T1 (HR)
Title: Peptides having pharmacological activity for treating disorders associated with altered cell migration, such as cancer
Inventor: CARRIERO MARIA VINCENZA
IPC: A61K38/03
Filed: 2013-04-12
Abstract: Peptides and their functionally equivalent derivatives, in salified or non-salified form, with the general formula L 1 -X 1 -X 2 -X 3 -X 4 , wherein: 
L 1  is H, or acyl, or any natural or non-natural amino acid, optionally N-acylated, N-alkylated and/or C±-alkylated; 
X 1  and X 3 , which are equal or different, are any natural or non-natural basic amino acid, optionally N-alkylated and/or C±-alkylated; 
X 2  is any natural or non-natural amino acid, optionally N-alkylated and/or C±-alkylated, with the proviso that it is not glycine and amino acids mono-substituted on the ± carbon atom with a linear or cyclic alkyl group, from 1 to 10 carbon atoms, and amino acids mono-substituted on the ± carbon atom with a linear or cyclic alkyl group containing 4 to 10 carbon atoms, or amino acids mono-substituted on the ± carbon atom with an alkyl group containing 1 to 8 carbon atoms, optionally substituted with a carbamoyl, hydroxyl or aromatic group; 
X 4  is any natural or non-natural hydrophobic amino acid, optionally C±-alkylated and/or amidated at the C-terminal end, or any hydrophobic amino alcohol, or a hydrophobic gem-diamine, optionally N'-alkylated or N'-acylated.
Patent SI-1539379-T1 (SI)
Title: Multilayer non-stick coating
Inventor: SHAH SATISH
IPC: C08K3/00
Filed: 2003-09-12
Abstract: A non-stick coating formed on a substrate comprising a primer composition and a topcoat composition, wherein the primer composition is between the topcoat composition and substrate. The primer composition comprises at least one heat resistant adhesion promoter. The topcoat composition comprises at least one fluorocarbon resin and at least one heat resistant adhesion promoter other than a fluoropolymer that may be the same or different than the adhesion promoter of the primer composition. There are inorganic inert particles with an average particle size of at least about 10 micrometers contained in the primer composition. The invention includes the method for forming the coating.
Patent SI-1592469-T1 (SI)
Title: A cover for an infusion site
Inventor: JENSEN SOREN
IPC: A61M5/00
Filed: 2004-02-11
Abstract: A cover (101) for an infusion device, comprising an upper plate element (103) with an upper face (104) and a lower face (105) oriented towards the upper face of the infusion device, wherein the lower face (105) of the plate element (103) comprises attachment means (106), cooperating with elements on the infusion device. The risk of bacteria and soil collected thereon penetrating into the construction is reduced considerably, and likewise the cover yields a smoother surface minimising the risk for the infusion device being torn off.
Patent SI-1649670-T1 (SI)
Title: Method for several mobile radio suppliers to jointly use a radio access network
Inventor: KLATT AXEL
IPC: H04W48/12
Filed: 2004-07-28
Abstract: The network sharing method has a single radio access network (9) used jointly by a number of different mobile radio service providers (A,B), each mobile radio network having a respective core network (6,7) serately operated by the service provider. Also included are Independent claims for the following: (A) an arrangement for operation of several mobile radio networks; (B) a method for selection of core elements of mobile radio networks.
Patent SI-2177494-T1 (SI)
Title: Method for waterproofing surfaces made of cement-based material
Inventor: PRANOVI SERGIO
IPC: C04B41/60
Filed: 2009-10-14
Abstract: Method for waterproofing surfaces made of cement-based material, comprising a step for preparing a surface to be treated by means of a mechanical abrasion process suitable to provide a rough surface; a step for consolidating the cement-based material by depositing on the rough surface a consolidating solution containing sodium silicate in solution, which is carried by the consolidating solution to impregnate the cement-based material in a 1.5 - 3 cm deep layer; a step of laying a primer on the rough surface treated with the consolidating solution; and a step for laying on the primer of a waterproofing coating made of elastomer resin.
Patent SI-2794126-T1 (SI)
Title: Method for producing homogeneous matt coatings by means of uv curing
Inventor: FISCHER WOLFGANG
IPC: C09D133/00
Filed: 2012-12-17
Abstract: The present invention relates to a method for producing matte and scratch-resistant coatings that are provided through the effect of actinic radiation on activated double bonds containing coating systems under radical polymerisation.
Patent SI-2884749-T1 (SI)
Title: Apparatus for decoding video accompanied with arithmetic decoding and two dimensional last significant coefficient signaling
Inventor: KIM IL-KOO
IPC: H04N19/00
Filed: 2012-06-27
Abstract: The present invention discloses a method for decoding a video through symbol decoding. Disclosed is the method for decoding the video, comprising the steps of: parsing symbols of image blocks from a bitstream which is received; performing arithmetic coding according to each arithmetic coding formula, which is individually decided with respect to a prefix bit string and a suffix bit string, by categorizing a current symbol into the prefix bit string and the suffix bit string with a critical value that is decided based on the size of the current block; and performing reverse binarization, after the arithmetic coding, according to each binarization formula, which is individually decided with respect to the prefix bit string and the suffix bit string.